Business · 21/05/2018Updated: 10/17/2026 · 1 min read
FDA Revokes Proposed Debarment Order Against Mary C. Holloway
Summary
The FDA has revoked a proposed order to debar Mary C. Holloway for 5 years from providing services related to approved or pending drug product applications, following her request for a hearing and submission of supporting information.